Oral idarubicin as a palliative agent in leukemia

Hematol Oncol. 1991 Jan-Feb;9(1):59-60. doi: 10.1002/hon.2900090108.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Oral
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / therapeutic use*
  • Leukemia / drug therapy*
  • Palliative Care*

Substances

  • Idarubicin